Polaris Partners

Polaris Partners is a Boston-based, multi-stage investment firm with deep healthcare and life-sciences expertise, having backed category-leading therapeutics, devices, diagnostics and digital health companies for decades. The healthcare practice spans early venture and growth stages, with particular strength in biotech, novel therapeutics platforms, and selective participation in healthcare technology where life-sciences pattern-matching applies. Check sizes are flexible by stage but typically meaningful, with venture investments in the $5M to $20M range and growth checks extending substantially higher, and the firm has the capacity to lead and to support companies through IPO trajectories. Geographic emphasis is US-centric with strong Boston roots, plus selective international engagement. For healthcare founders, Polaris is highly relevant if you are building a science-driven therapeutics, biotech platform or life-sciences company with strong scientific foundations and a clear regulatory and clinical pathway, where a Boston-anchored multi-stage healthcare specialist adds capital, scientific diligence depth and IPO-pathway credibility. The firm is a poor fit for digital-only health, healthcare services, healthcare IT and AI-only software businesses where a healthcare-services or generalist investor would be better aligned, and pre-formation life-sciences founders should target seed-specialist biotech accelerators first. Entry is best via warm introductions from existing portfolio CEOs, life-sciences-focused co-investors, scientific advisors with Polaris relationships, or sector investment bankers. Cold outbound is significantly less effective at this profile of firm; a high-quality warm introduction substantially improves response and timeline.